Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/1996
09/26/1996CA2211179A1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system
09/25/1996EP0733361A2 Method for inactivating enveloped viruses and sperm
09/25/1996EP0733111A1 IFN-$g(g)RECEPTOR $g(b)-CHAIN AND DERIVATIVES THEREOF
09/25/1996EP0733107A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
09/25/1996EP0733067A1 N-terminally chemically modified protein compositions and methods
09/25/1996EP0733057A1 Origin of replication complex genes, proteins and methods
09/25/1996EP0733055A1 2-spiro(2'-spirocycloalkyl)cyclopropyl cephalosporin sulfones as antiinflammatory and antidegenerative agents
09/25/1996EP0733054A1 Novel quinolone compounds and processes for the preparation thereof
09/25/1996EP0733053A1 Oxathiolanes, method for their preparation and pharmaceutical compositions containing same
09/25/1996EP0733043A1 Tricyclic derivatives and their use in pharmaceuticals
09/25/1996EP0733035A1 Tricyclic derivatives, pharmaceutical compositions containing them
09/25/1996EP0732944A1 Labeled chemotactic peptides to image focal sites of infection or inflammation
09/25/1996EP0732938A1 Method of treating intestinal disorders
09/25/1996EP0732918A1 Benzalkonium fluoride injectable solution
09/25/1996EP0674513B1 Retroviral protease inhibiting compounds
09/25/1996EP0587805B1 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1
09/25/1996CN1131946A Distamycin A analogues as antitumour or antiviral agents
09/25/1996CN1131942A HIV protease inhibitors
09/25/1996CN1131540A Preparation method of medicine for curing syphilopathy
09/25/1996CA2171518A1 Process for the preparation of 2,2'-anhydro- and 2' -keto-1-(3', 5'-di-o-protected-.beta.-d-arabinofuranosyl) nucleosides
09/24/1996US5559256 Aminediol protease inhibitors
09/24/1996US5559250 Treating red blood cell solutions with anti-viral agents
09/24/1996US5559249 7'-amino-naphthazarin antibiotic derivatives
09/24/1996US5559225 7-acyl-3-(substituted carbamoyloxy) cephem compound
09/24/1996US5559224 Carbepenem derivatives
09/24/1996US5559222 Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
09/24/1996US5559211 Biologically active product produced by streptococcus pyogenes and method of purification
09/24/1996US5559152 Pharmaceutical composition having antiacoholic activity
09/24/1996US5559133 Orally active antiviral compounds
09/24/1996US5559122 Hindered N-oxide esters of rapamycin
09/24/1996US5559121 Rapamycin formulations for oral administration
09/24/1996US5559108 Antibiotics
09/24/1996US5559098 Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic
09/24/1996US5559096 Pharmaceutical compositions against gastric disorders
09/24/1996US5559025 Expression of mature proteinase 2A, the partial purification thereof and preparation of substrates having an inhibitory effect
09/24/1996US5559011 Nucleic acids encoding membrane-associated immunogens of mycobacterial and corresponding probes, vectors, and transformed host cells
09/24/1996US5558863 Method for treatment of herpes virus infections
09/19/1996WO1996028563A1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
09/19/1996WO1996028552A1 Rheumatoid arthritis-related virus msrv-1 and pathogenic and/or infective agent msrv-2
09/19/1996WO1996028551A1 Vaccines for plague
09/19/1996WO1996028544A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
09/19/1996WO1996028472A1 Antigen composition against mycoplasma
09/19/1996WO1996028467A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition
09/19/1996WO1996028465A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996WO1996028464A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996WO1996028463A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996WO1996028456A1 Antibiotics tkr1912-i and tkr1912-ii and process for producing the same
09/19/1996WO1996028453A1 Processes for the production of 2-isocephem derivatives
09/19/1996WO1996028418A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996WO1996028167A1 Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin b6
09/19/1996WO1996021463A3 New applications of lysozyme dimer
09/19/1996CA2215061A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996CA2215025A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996CA2215022A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996CA2214799A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
09/18/1996EP0732340A2 Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell
09/18/1996EP0732339A1 Peptides of the HIV-gag protein, their preparation and use
09/18/1996EP0731839A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
09/18/1996EP0731810A1 Double-chain hemoregulatory peptides
09/18/1996EP0731808A1 Nucleosides and oligonucleotides containing boron clusters
09/18/1996EP0731807A1 N-2 substituted purines
09/18/1996EP0731801A1 Substituted aminoalkylaminopyridines
09/18/1996EP0731792A1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action
09/18/1996EP0731790A1 Tachykinin antagonists
09/18/1996EP0731789A1 Dp-iv-serine protease inhibitors
09/18/1996EP0731697A1 Ssi tyrphostins and pharmaceutical compositions
09/18/1996EP0731696A1 Cysteine protease inhibitors containing heterocyclic leaving groups
09/18/1996EP0666855B1 4-quinolinyl derivatives with anti-helicobacter activity
09/18/1996EP0565631B1 Anti-viral compounds
09/18/1996EP0560794B1 Substituted 1,3-oxathiolanes with antiviral properties
09/18/1996EP0531370B1 Inhibition of viral infection
09/18/1996EP0527941B1 Identification of novel drugs and reagents
09/18/1996EP0511991B1 Pharmaceutical formulation containing penciclovir
09/18/1996CN1131439A Chitinase DNA coding thereof and plants containing same
09/18/1996CN1131421A Novel substituted propane-2-ol derivatives
09/18/1996CN1131420A Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
09/18/1996CN1131192A Recombinant mersacidin and method for production
09/17/1996US5556979 7-isoindolinyl-naphthyridone derivatives, compositions and anti-bacterial use thereof
09/17/1996US5556942 Glutathione S-transferase-activated compounds
09/17/1996US5556886 HIV-inhibiting benzeneacetamide derivatives
09/17/1996US5556875 1,2-dithiin antiinfective agents
09/17/1996US5556870 Use of leflunomide for inhibiting interleukin 1 beta
09/17/1996US5556863 Antiinflammatory agents and antisecretory agents for gastric juice
09/17/1996US5556850 Bactericides
09/17/1996US5556843 Treatment of central nervous system disorders, inhibits activation of protein kinase c
09/17/1996US5556840 2',5'-phosphorothioate oligoadenylates as anitiviral agents
09/17/1996US5556763 Patterns of transcription factors and lymphocytes
09/17/1996US5556639 Lamotrigine anticonvulsant
09/17/1996CA2086763C Sewing machine needle and method for manufacturing same
09/12/1996WO1996027664A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
09/12/1996WO1996027606A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom
09/12/1996WO1996027603A1 Compositions and methods for the treatment and diagnosis of immune disorders
09/12/1996WO1996027593A1 Arginine analogues having nitric oxide synthase inhibitor activity
09/12/1996WO1996027583A1 Arylsulfonylamino hydroxamic acid derivatives
09/12/1996WO1996027390A1 Compositions and methods for stimulating antibody class switching
09/12/1996WO1996027383A1 Compositions having antiviral properties and preparation process
09/12/1996WO1996027378A2 Use of penciclovir for the treatment of human herpes-virus-8
09/12/1996WO1996027292A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
09/12/1996WO1996021670A3 Antifungal fusacandins
09/12/1996WO1996021468A3 Chemically modified interferon
1 ... 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 ... 1798